Showing results (251-260 of 297) with videos related to
Sort By:
Pageof 30
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2021
Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid LeukemiaCourtney D DiNardo, Curtis A Lachowiez, Koichi Takahashi, et al.Leukemia|March 12, 2026
Immunophenotypic changes following menin inhibition in acute myeloid leukemiaSanam Loghavi, Aziz Farhat, Trevor J Jamison, et al.Blood|November 5, 2025
Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapySven Turkalj, Felix A Radtke, Bilyana Stoilova, et al.Cancer|April 29, 2021
Clinicopathologic correlates and natural history of atypical chronic myeloid leukemiaGuillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Koji Sasaki, et al.American Journal of Hematology|May 18, 2022
Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemiaCourtney D DiNardo, Curtis A Lachowiez, Koichi Takahashi, et al.Nature Immunology|June 29, 2026
Inflammatory immune modulators of AML lung infiltration and respiratory failureVarvara Paraskevopoulou, Ziyan Lin, Marta Casado-Pelaez, et al.Cancer|May 6, 2026
Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapyJennifer Marvin-Peek, Courtney D DiNardo, Sanam Loghavi, et al.American Journal of Hematology|September 2, 2022
Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatmentCurtis A Lachowiez, Patrick K Reville, Hagop Kantarjian, et al.Blood Cancer Discovery|March 8, 2021
Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 inhibitorsAhmad S Alotaibi, Musa Yilmaz, Rashmi Kanagal-Shamanna, et al.Journal of Hematology & Oncology|October 9, 2020
Outcomes with sequential FLT3-inhibitor-based therapies in patients with AMLMusa Yilmaz, Mansour Alfayez, Courtney D DiNardo, et al.Pageof 30